tiprankstipranks
Trending News
More News >
Ginkgo Bioworks Holdings (DNA)
NYSE:DNA
US Market

Ginkgo Bioworks Holdings (DNA) Ratios

Compare
2,194 Followers

Ginkgo Bioworks Holdings Ratios

DNA's free cash flow for Q4 2024 was $0.78. For the 2024 fiscal year, DNA's free cash flow was decreased by $ and operating cash flow was $-3.63. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
5.62 6.11 8.38 12.79 5.83
Quick Ratio
5.62 6.11 8.36 12.76 5.79
Cash Ratio
5.24 5.76 7.61 11.50 5.20
Solvency Ratio
-0.73 -1.45 -2.54 -3.58 -0.55
Operating Cash Flow Ratio
-2.98 -1.80 -1.46 -1.88 -1.86
Short-Term Operating Cash Flow Coverage
0.00 0.00 0.00 0.00 0.00
Net Current Asset Value
$ -58.65M$ 433.56M$ 647.03M$ 1.22B$ 221.44M
Leverage Ratios
Debt-to-Assets Ratio
0.32 0.15 0.17 0.01 0.03
Debt-to-Equity Ratio
0.61 0.22 0.25 0.02 0.04
Debt-to-Capital Ratio
0.38 0.18 0.20 0.02 0.04
Long-Term Debt-to-Capital Ratio
0.38 0.00 0.00 0.00 -0.37
Financial Leverage Ratio
1.92 1.52 1.46 1.38 1.46
Debt Service Coverage Ratio
-5.15K -8.83K -19.29K -760.72 -46.32
Interest Coverage Ratio
-5.95K -9.29K -20.84K -770.53 -57.45
Debt to Market Cap
0.86 0.00 0.00 0.00 >-0.01
Interest Debt Per Share
8.46 4.98 10.55 0.75 0.01
Net Debt to EBITDA
0.25 0.86 0.42 0.85 3.35
Profitability Margins
Gross Profit Margin
83.02%78.52%57.25%58.68%79.64%
EBIT Margin
-241.19%-355.07%-444.06%-584.94%-159.74%
EBITDA Margin
-213.35%-326.62%-431.16%-575.67%-141.65%
Operating Profit Margin
-246.54%-343.76%-462.41%-582.62%-178.75%
Pretax Profit Margin
-241.15%-355.11%-444.08%-585.69%-162.85%
Net Profit Margin
-240.94%-355.08%-440.63%-583.12%-165.16%
Continuous Operations Profit Margin
-240.94%-355.08%-440.93%-585.22%-165.31%
Net Income Per EBT
99.91%99.99%99.22%99.56%101.42%
EBT Per EBIT
97.81%103.30%96.04%100.53%91.10%
Return on Assets (ROA)
-39.71%-53.61%-82.89%-88.37%-18.75%
Return on Equity (ROE)
-76.39%-81.38%-121.23%-121.57%-27.44%
Return on Capital Employed (ROCE)
-44.07%-57.57%-93.35%-94.43%-22.76%
Return on Invested Capital (ROIC)
-44.03%-56.81%-91.55%-94.32%-23.09%
Return on Tangible Assets
-41.92%-58.23%-88.89%-90.24%-18.90%
Earnings Yield
-107.34%-27.22%-74.18%-16.19%-0.02%
Efficiency Ratios
Receivables Turnover
10.39 7.92 5.79 2.09 3.50
Payables Turnover
2.72 5.79 19.54 15.84 1.12
Inventory Turnover
0.00 1.17K 46.80 38.58 5.71
Fixed Asset Turnover
0.38 0.63 0.67 2.15 0.63
Asset Turnover
0.16 0.15 0.19 0.15 0.11
Working Capital Turnover Ratio
0.34 0.24 0.33 0.32 0.19
Cash Conversion Cycle
-99.02 -16.63 52.13 160.75 -156.56
Days of Sales Outstanding
35.14 46.07 63.01 174.34 104.30
Days of Inventory Outstanding
0.00 0.31 7.80 9.46 63.97
Days of Payables Outstanding
134.16 63.01 18.68 23.05 324.83
Operating Cycle
35.14 46.38 70.81 183.80 168.28
Cash Flow Ratios
Operating Cash Flow Per Share
-6.16 -6.09 -6.01 -7.47 -0.09
Free Cash Flow Per Share
-7.36 -6.93 -7.25 -9.13 -0.13
CapEx Per Share
1.21 0.84 1.25 1.66 0.04
Free Cash Flow to Operating Cash Flow
1.20 1.14 1.21 1.22 1.43
Dividend Paid and CapEx Coverage Ratio
-5.11 -7.24 -4.82 -4.49 -2.35
Capital Expenditure Coverage Ratio
-5.11 -7.24 -4.82 -4.49 -2.35
Operating Cash Flow Coverage Ratio
-0.73 -1.22 -0.57 -11.02 -7.99
Operating Cash Flow to Sales Ratio
-1.41 -1.18 -0.53 -0.81 -1.77
Free Cash Flow Yield
-74.98%-10.25%-10.73%-2.75%-0.03%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
-0.93 -3.67 -1.35 -6.17 -4.75K
Price-to-Sales (P/S) Ratio
2.24 13.05 5.94 36.01 7.84K
Price-to-Book (P/B) Ratio
0.71 2.99 1.63 7.51 1.30K
Price-to-Free Cash Flow (P/FCF) Ratio
-1.33 -9.75 -9.32 -36.41 -3.10K
Price-to-Operating Cash Flow Ratio
-1.59 -11.10 -11.25 -44.52 -4.43K
Price-to-Earnings Growth (PEG) Ratio
0.02 0.06 0.20 >-0.01 -779.08
Price-to-Fair Value
0.71 2.99 1.63 7.51 1.30K
Enterprise Value Multiple
-0.80 -3.14 -0.95 -5.41 -5.53K
EV to EBITDA
-0.80 -3.14 -0.95 -5.41 -5.53K
EV to Sales
1.70 10.25 4.11 31.14 7.84K
EV to Free Cash Flow
-1.01 -7.67 -6.45 -31.49 -3.10K
EV to Operating Cash Flow
-1.21 -8.72 -7.79 -38.51 -4.42K
Tangible Book Value Per Share
12.40 19.89 37.28 44.84 0.31
Shareholders’ Equity Per Share
13.80 22.61 41.36 44.28 0.31
Tax and Other Ratios
Effective Tax Rate
<0.01 <0.01 <0.01 <0.01 -0.02
Revenue Per Share
4.38 5.18 11.38 9.23 0.05
Net Income Per Share
-10.54 -18.40 -50.15 -53.83 -0.09
Tax Burden
1.00 1.00 0.99 1.00 1.01
Interest Burden
1.00 1.00 1.00 1.00 1.02
Research & Development to Revenue
1.87 2.31 2.20 3.66 2.08
SG&A to Revenue
1.08 1.53 2.99 2.75 0.50
Stock-Based Compensation to Revenue
0.49 0.91 4.04 5.12 <0.01
Income Quality
0.58 0.33 0.12 0.14 1.07
Currency in USD
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis